Pfizer Inc is > 10% Shareholder of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 27.3 Million shares of CERE, which is worth approximately $1.12 Billion. The most recent transaction as insider was on Oct 27, 2020, when has been sold 1,200,000 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $12,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.3M
0% 3M change
0% 12M change
Total Value Held $1.12 Billion

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2020
BUY
Open market or private purchase
$12,000,000 $10.0 p/Share
1,200,000 Added 4.2%
27,349,211 Common Stock

Also insider at

ICUI
ICU MEDICAL INC Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
CRTX
Cortexyme, Inc. Healthcare
SWTX
SpringWorks Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
VTRS
Viatris Inc Healthcare
BCAB
BioAtla, Inc. Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
PI

Pfizer Inc

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Track Activities on CERE